Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 13;9(7):812.
doi: 10.3390/biomedicines9070812.

Animal Models of Autosomal Recessive Parkinsonism

Affiliations
Review

Animal Models of Autosomal Recessive Parkinsonism

Guendalina Bastioli et al. Biomedicines. .

Abstract

Parkinson's disease (PD) is the most common neurodegenerative movement disorder. The neuropathological hallmark of the disease is the loss of dopamine neurons of the substantia nigra pars compacta. The clinical manifestations of PD are bradykinesia, rigidity, resting tremors and postural instability. PD patients often display non-motor symptoms such as depression, anxiety, weakness, sleep disturbances and cognitive disorders. Although, in 90% of cases, PD has a sporadic onset of unknown etiology, highly penetrant rare genetic mutations in many genes have been linked with typical familial PD. Understanding the mechanisms behind the DA neuron death in these Mendelian forms may help to illuminate the pathogenesis of DA neuron degeneration in the more common forms of PD. A key step in the identification of the molecular pathways underlying DA neuron death, and in the development of therapeutic strategies, is the creation and characterization of animal models that faithfully recapitulate the human disease. In this review, we outline the current status of PD modeling using mouse, rat and non-mammalian models, focusing on animal models for autosomal recessive PD.

Keywords: Parkinson’s disease; animal model; autosomal recessive Parkinsonism; dopaminergic neurons.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Subcellular localization of proteins encoded by genes involved in autosomal recessive Parkinson’s disease.
Figure 2
Figure 2
Animal models for the study of autosomal recessive Parkinson’s disease.

References

    1. GBD 2016 Parkinson’s Disease Collaborators Global, regional, and national burden of Parkinson’s disease, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:939–953. doi: 10.1016/S1474-4422(18)30295-3. - DOI - PMC - PubMed
    1. Shulman J.M., De Jager P.L., Feany M.B. Parkinson’s disease: Genetics and pathogenesis. Annu. Rev. Pathol. 2011;6:193–222. doi: 10.1146/annurev-pathol-011110-130242. - DOI - PubMed
    1. Obeso J.A., Stamelou M., Goetz C.G., Poewe W., Lang A.E., Weintraub D., Burn D., Halliday G.M., Bezard E., Przedborski S., et al. Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov. Disord. 2017;32:1264–1310. doi: 10.1002/mds.27115. - DOI - PMC - PubMed
    1. Deng H., Wang P., Jankovic J. The genetics of Parkinson disease. Ageing Res. Rev. 2018;42:72–85. doi: 10.1016/j.arr.2017.12.007. - DOI - PubMed
    1. Vingill S., Connor-Robson N., Wade-Martins R. Are rodent models of Parkinson’s disease behaving as they should? Behav. Brain Res. 2018;352:133–141. doi: 10.1016/j.bbr.2017.10.021. - DOI - PubMed